title: Dramatic efficiency of pegylated interferon in sinus histiocytosis with massive lymphadenopathy.
authors.forename: G
authors.initials: G
authors.lastname: Le Guenno
authors.forename: L
authors.initials: L
authors.lastname: Galicier
authors.forename: C
authors.initials: C
authors.lastname: Fieschi
authors.forename: V
authors.initials: V
authors.lastname: Meignin
authors.forename: A
authors.initials: A
authors.lastname: Chabrol
authors.forename: E
authors.initials: E
authors.lastname: Oksenhendler
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D001706:Biopsy; D005260:Female; D015618:Histiocytosis, Sinus / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a